Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
November 23, 2021
Patent Application Number
16851420
Date Filed
April 17, 2020
Patent Citations Received
Patent Primary Examiner
Patent abstract
The disclosure provides compositions and methods for the treatment of ocular conditions associated with angiogenesis comprising administering an antibody that targets a tyrosine phosphatase inhibitor in a subject.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
